These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 23473693)

  • 1. Place of proton radiotherapy in future radiotherapy practice.
    Zips D; Baumann M
    Semin Radiat Oncol; 2013 Apr; 23(2):149-53. PubMed ID: 23473693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controversies in clinical trials in proton radiotherapy: the present and the future.
    Miller RC; Lodge M; Murad MH; Jones B
    Semin Radiat Oncol; 2013 Apr; 23(2):127-33. PubMed ID: 23473690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
    Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
    Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical controversies: proton radiation therapy for brain and skull base tumors.
    Combs SE; Laperriere N; Brada M
    Semin Radiat Oncol; 2013 Apr; 23(2):120-6. PubMed ID: 23473689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physics controversies in proton therapy.
    Engelsman M; Schwarz M; Dong L
    Semin Radiat Oncol; 2013 Apr; 23(2):88-96. PubMed ID: 23473685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetric advantages of IMPT over IMRT for laser-accelerated proton beams.
    Luo W; Li J; Fourkal E; Fan J; Xu X; Chen Z; Jin L; Price R; Ma CM
    Phys Med Biol; 2008 Dec; 53(24):7151-66. PubMed ID: 19033641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical controversies: proton therapy for thoracic tumors.
    De Ruysscher D; Chang JY
    Semin Radiat Oncol; 2013 Apr; 23(2):115-9. PubMed ID: 23473688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetry of clinical neutron and proton beams: an overview of recommendations.
    Vynckier S; ;
    Radiat Prot Dosimetry; 2004; 110(1-4):565-72. PubMed ID: 15353710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton-beam therapy for tumors of the CNS.
    Gridley DS; Grover RS; Loredo LN; Wroe AJ; Slater JD
    Expert Rev Neurother; 2010 Feb; 10(2):319-30. PubMed ID: 20136386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical controversies: proton therapy for pediatric tumors.
    Merchant TE
    Semin Radiat Oncol; 2013 Apr; 23(2):97-108. PubMed ID: 23473686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological, physical factors in clinical assessment of outcome of cancer therapy.
    Perez CA
    Rays; 2005; 30(2):85-98. PubMed ID: 16294900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of technology to optimize the delivery of proton therapy: the third generation.
    Flanz J; Bortfeld T
    Semin Radiat Oncol; 2013 Apr; 23(2):142-8. PubMed ID: 23473692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Number of patients potentially eligible for proton therapy.
    Glimelius B; Ask A; Bjelkengren G; Björk-Eriksson T; Blomquist E; Johansson B; Karlsson M; Zackrisson B
    Acta Oncol; 2005; 44(8):836-49. PubMed ID: 16332591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress of radiation oncology: known and unknown.
    Liu J; Yu J
    Chin Med J (Engl); 2014; 127(11):2173-9. PubMed ID: 24890173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can Technological Improvements Reduce the Cost of Proton Radiation Therapy?
    Schippers JM; Lomax A; Garonna A; Parodi K
    Semin Radiat Oncol; 2018 Apr; 28(2):150-159. PubMed ID: 29735191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered fractionation in radiotherapy: from radiobiological rationale to therapeutic gain.
    Marcu LG
    Cancer Treat Rev; 2010 Dec; 36(8):606-14. PubMed ID: 20494524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal tissue complications from low-dose proton therapy.
    Mahajan A
    Health Phys; 2012 Nov; 103(5):586-9. PubMed ID: 23032888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of the impact of photon and proton external beam radiotherapy treatment modalities on the dose distribution in field and out-of-field; implications for the long-term morbidity of cancer survivors.
    Palm A; Johansson KA
    Acta Oncol; 2007; 46(4):462-73. PubMed ID: 17497313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton therapy: clinical gains through current and future treatment programs.
    Mohan R; Bortfeld T
    Front Radiat Ther Oncol; 2011; 43():440-464. PubMed ID: 21625168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.